drugset / Trial / NCT03640156

Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin

NCT03640156

Phase 3 Completed 25 enrolled KU Leuven
RandomizedCrossoverTriple-blindBasic science

Summary

This study investigates the efficacy of a single-dose of exogenous oxytocin administration on socially adaptive mirror-motor mapping in participants with Autism Spectrum Disorders. A placebo-controlled cross-over trial will be conducted: each participant will receive both a single-dose of placebo and oxytocin in two sessions separated by one week. The order of nasal spray will be randomised across participants. Mirror-motor mapping will be assessed by transcranial magnetic stimulation (TMS), a standard technique to investigate mirror system activity.

Timeline

Start
2018-07-26
Primary completion
2019-12-19
Completion
2019-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal